Content by analytica
| 2 min read
analytica will launch analytica USA in Columbus, Ohio, in fall 2025, to cover the North American market.
| 5 min read
Oncology drug discovery faces one of the highest attrition rates for drug candidates in the
development pipeline, largely due to efficacy issues. More relevant clinical models, ones that better reflect cancer heterogeneity and disease progression,
could address this problem.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe